BioCryst Pharmaceuticals
BCRX
BCRX
256 hedge funds and large institutions have $1.31B invested in BioCryst Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 80 increasing their positions, 73 reducing their positions, and 35 closing their positions.
Holders
256
Holders Change
+15
Holders Change %
+6.22%
% of All Funds
3.7%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
52
Increased
80
Reduced
73
Closed
35
Calls
$12.6M
Puts
$6.44M
Net Calls
+$6.19M
Net Calls Change
+$6.47M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$154M |
2 |
JAM
2
Jupiter Asset Management
London,
United Kingdom
|
$8.13M |
3 |
3
BlackRock
New York
|
$159M |
4 |
4
Invesco
Atlanta,
Georgia
|
$7.64M |
5 |
5
Prudential Financial
Newark,
New Jersey
|
$6.78M |